GB0139, an inhaled small molecule inhibitor of galectin-3, in COVID-19 pneumonitis: a randomised, controlled, open-label, phase 2a experimental medicine trial of safety, pharmacokinetics, and potential therapeutic value
Erin Gaughan, Tariq Sethi, Tom Quinn, Nikhil Hirani, Andrew Mills, Annya M. Bruce, Alison MacKinnon, Vassilios Aslanis, Feng Li, Richard O’Connor, Richard A. Parker, John Norrie, View ORCID ProfileJames Dear, Ahsan R. Akram, Oliver Koch, Jie Wang-Jairaj, Robert J. Slack, Lise Gravelle, Bertil Lindmark, Kevin Dhaliwal
doi: https://doi.org/10.1101/2021.12.21.21267983
Erin Gaughan
1Centre for Inflammation Research, Edinburgh BioQuarter, University of Edinburgh, Edinburgh, UK
2Department of Respiratory Medicine, New Royal Infirmary of Edinburgh, Edinburgh BioQuarter, Edinburgh, UK
Tariq Sethi
3Galecto Inc. Ole Maaloes Vej 3, Copenhagen, Denmark
Tom Quinn
1Centre for Inflammation Research, Edinburgh BioQuarter, University of Edinburgh, Edinburgh, UK
Nikhil Hirani
1Centre for Inflammation Research, Edinburgh BioQuarter, University of Edinburgh, Edinburgh, UK
2Department of Respiratory Medicine, New Royal Infirmary of Edinburgh, Edinburgh BioQuarter, Edinburgh, UK
Andrew Mills
4Exploristics, Belfast, UK
Annya M. Bruce
1Centre for Inflammation Research, Edinburgh BioQuarter, University of Edinburgh, Edinburgh, UK
Alison MacKinnon
3Galecto Inc. Ole Maaloes Vej 3, Copenhagen, Denmark
Vassilios Aslanis
3Galecto Inc. Ole Maaloes Vej 3, Copenhagen, Denmark
Feng Li
1Centre for Inflammation Research, Edinburgh BioQuarter, University of Edinburgh, Edinburgh, UK
Richard O’Connor
1Centre for Inflammation Research, Edinburgh BioQuarter, University of Edinburgh, Edinburgh, UK
Richard A. Parker
5Edinburgh Clinical Trials Unit, Usher Institute, University of Edinburgh, Edinburgh, UK
John Norrie
5Edinburgh Clinical Trials Unit, Usher Institute, University of Edinburgh, Edinburgh, UK
James Dear
6Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK
Ahsan R. Akram
1Centre for Inflammation Research, Edinburgh BioQuarter, University of Edinburgh, Edinburgh, UK
2Department of Respiratory Medicine, New Royal Infirmary of Edinburgh, Edinburgh BioQuarter, Edinburgh, UK
Oliver Koch
7Infectious Diseases Department, NHS Lothian, Edinburgh, UK
Jie Wang-Jairaj
3Galecto Inc. Ole Maaloes Vej 3, Copenhagen, Denmark
Robert J. Slack
3Galecto Inc. Ole Maaloes Vej 3, Copenhagen, Denmark
Lise Gravelle
3Galecto Inc. Ole Maaloes Vej 3, Copenhagen, Denmark
Bertil Lindmark
3Galecto Inc. Ole Maaloes Vej 3, Copenhagen, Denmark
Kevin Dhaliwal
1Centre for Inflammation Research, Edinburgh BioQuarter, University of Edinburgh, Edinburgh, UK
2Department of Respiratory Medicine, New Royal Infirmary of Edinburgh, Edinburgh BioQuarter, Edinburgh, UK
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted January 10, 2022.
GB0139, an inhaled small molecule inhibitor of galectin-3, in COVID-19 pneumonitis: a randomised, controlled, open-label, phase 2a experimental medicine trial of safety, pharmacokinetics, and potential therapeutic value
Erin Gaughan, Tariq Sethi, Tom Quinn, Nikhil Hirani, Andrew Mills, Annya M. Bruce, Alison MacKinnon, Vassilios Aslanis, Feng Li, Richard O’Connor, Richard A. Parker, John Norrie, James Dear, Ahsan R. Akram, Oliver Koch, Jie Wang-Jairaj, Robert J. Slack, Lise Gravelle, Bertil Lindmark, Kevin Dhaliwal
medRxiv 2021.12.21.21267983; doi: https://doi.org/10.1101/2021.12.21.21267983
GB0139, an inhaled small molecule inhibitor of galectin-3, in COVID-19 pneumonitis: a randomised, controlled, open-label, phase 2a experimental medicine trial of safety, pharmacokinetics, and potential therapeutic value
Erin Gaughan, Tariq Sethi, Tom Quinn, Nikhil Hirani, Andrew Mills, Annya M. Bruce, Alison MacKinnon, Vassilios Aslanis, Feng Li, Richard O’Connor, Richard A. Parker, John Norrie, James Dear, Ahsan R. Akram, Oliver Koch, Jie Wang-Jairaj, Robert J. Slack, Lise Gravelle, Bertil Lindmark, Kevin Dhaliwal
medRxiv 2021.12.21.21267983; doi: https://doi.org/10.1101/2021.12.21.21267983
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (671)
- Anesthesia (181)
- Cardiovascular Medicine (2661)
- Dermatology (224)
- Emergency Medicine (402)
- Epidemiology (12264)
- Forensic Medicine (10)
- Gastroenterology (765)
- Genetic and Genomic Medicine (4122)
- Geriatric Medicine (387)
- Health Economics (681)
- Health Informatics (2670)
- Health Policy (1008)
- Hematology (364)
- HIV/AIDS (855)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (442)
- Neurology (3912)
- Nursing (210)
- Nutrition (582)
- Oncology (2048)
- Ophthalmology (587)
- Orthopedics (242)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1116)
- Primary Care Research (455)
- Public and Global Health (6551)
- Radiology and Imaging (1410)
- Respiratory Medicine (872)
- Rheumatology (412)
- Sports Medicine (344)
- Surgery (452)
- Toxicology (54)
- Transplantation (186)
- Urology (167)